• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    India Structural Heart Devices Market

    ID: MRFR/HC/55142-HCR
    200 Pages
    Garvit Vyas
    October 2025

    India Structural Heart Devices Market Research Report: By Type (Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems), By Indication (Valvular Heart Disease, Cardiomyopathy) andBy Procedure (Replacement Procedures, Repair Procedures)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    India Structural Heart Devices Market Infographic
    Purchase Options

    India Structural Heart Devices Market Summary

    The India Structural Heart Devices market is projected to grow significantly from 35.5 USD Million in 2024 to 95 USD Million by 2035.

    Key Market Trends & Highlights

    India Structural Heart Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 9.36 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 95 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 35.5 USD Million, reflecting the current demand for structural heart devices in India.
    • Growing adoption of advanced medical technologies due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 35.5 (USD Million)
    2035 Market Size 95 (USD Million)
    CAGR (2025-2035) 9.36%

    Major Players

    Cardinal Health, Merit Medical Systems, Terumo Corporation, Edwards Lifesciences, Abbott, Alcon, Stryker, Janssen Pharmaceuticals, Corindus Vascular Robotics, Boston Scientific, LivaNova, AtriCure, Medtronic, Glenveigh Medical, Pleura Technologies

    India Structural Heart Devices Market Trends

    The India Structural Heart Devices Market is experiencing significant growth due to a combination of key market drivers. One of the primary drivers is the increasing prevalence of structural heart diseases, particularly among the aging population. With the Indian government emphasizing healthcare improvements and innovation, there is a push for better management and treatment options for heart diseases. 

    Furthermore, advancements in technology and medical devices are leading to more effective and less invasive treatment options, thus attracting both healthcare providers and patients alike. Opportunities to be explored include the growing demand for minimally invasive procedures and devices, which becoming a preferred choice for patients and healthcare providers due to shorter recovery times and reduced hospital stays.Additionally, the rising disposable incomes among the urban population in India create a favorable environment for investing in advanced medical technologies, including structural heart devices. 

    Trends in recent times show a heightened focus on research and development in the Indian healthcare sector, particularly in the field of cardiovascular treatments. This is supported by various government initiatives aimed at boosting healthcare infrastructure and fostering innovation. Collaborations between Indian hospitals and international medical device manufacturers are also on the rise, paving the way for new product introductions tailored to local healthcare needs.With increasing awareness about structural heart diseases and ongoing education for both patients and healthcare professionals, there is a growing recognition of the importance of timely interventions.

    Overall, the India Structural Heart Devices Market stands poised for significant advancements and expansion in the coming years.

    Market Segment Insights

    Structural Heart Devices Market Type Insights

    The India Structural Heart Devices Market is characterized by a diverse array of devices that play a critical role in the management of structural heart diseases. This market encompasses various categories such as Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems, each contributing uniquely to ensuring improved patient outcomes and operational efficiency in healthcare facilities. Heart Valve Devices are crucial as they are increasingly being adopted for minimally invasive procedures, significantly reducing recovery times and surgical risks for patients.

    Moreover, the growing prevalence of heart diseases in India serves as a significant growth driver for this segment, buoyed by an aging population and lifestyle changes leading to increased cardiovascular risks.

    Annuloplasty Rings, which support the restoration of heart valve function, have gained traction due to their effectiveness in mitral and tricuspid valve repair, presenting exciting opportunities for surgical advancements in India. As healthcare institutions invest in modernizing their cardiac facilities, these devices are increasingly being utilized to enhance surgical outcomes and streamline procedures. Meanwhile, Occluders, designed for the treatment of conditions such as atrial septal defects, are beneficial in preventing complications associated with abnormal blood flow. They are appreciated for their minimally invasive nature, further fostering their demand amidst rising healthcare awareness among the Indian population.

    Get more detailed insights about India Structural Heart Devices Market Research Report - Forecast to 2035

    Key Players and Competitive Insights

    The India Structural Heart Devices Market has been experiencing significant growth due to an increasing prevalence of cardiovascular diseases and an aging population. Competitive insights into this market reveal a landscape characterized by innovative technological advancements and a focus on minimally invasive procedures. Companies operating in this sector are focusing on enhancing their product portfolios with advanced devices that cater to the specific needs of the Indian healthcare environment. 

    Key players are engaging in strategic partnerships and collaborations to broaden their market reach and improve patient outcomes. With a growing emphasis on research and development, companies are also investing in developing new technologies aimed at improving the efficiency and safety of heart procedures, which is critical given the rising incidence of heart ailments in India.Cardinal Health has proved to be a formidable player in the India Structural Heart Devices Market through its commitment to quality and innovation. 

    The company has established a strong presence by offering a wide range of products designed specifically for structural heart diseases. Cardinal Health's strengths lie in its robust distribution network and strong customer relationships, which have facilitated the widespread adoption of its devices in hospitals and clinics across India. Furthermore, the company's continuous focus on training healthcare professionals ensures effective usage of its products, thereby enhancing patient care. 

    The combination of advanced technology, strategic partnerships, and a deep understanding of the Indian market has allowed Cardinal Health to stand out amid increasing competition.Merit Medical Systems holds a notable position in the India Structural Heart Devices Market, providing various innovative solutions tailored for cardiovascular treatments. The company specializes in a diverse range of products, including those used in transcatheter procedures, guiding catheters, and other vital instruments that play a critical role in structural heart interventions. 

    Merit Medical Systems benefits from its strategic focus on innovation and the continuous expansion of its product portfolio to meet the evolving needs of the Indian market. The company has also pursued key partnerships and potential mergers to enhance its capabilities and market standing in India. Its dedication to quality and patient safety, coupled with strong relationships with healthcare providers, positions Merit Medical Systems favorably within this competitive landscape.

    Key Companies in the India Structural Heart Devices Market market include

    Industry Developments

    The India Structural Heart Devices Market has seen significant developments recently, with key players like Abbott, Edwards Lifesciences, and Boston Scientific actively expanding their product offerings and market presence. In April 2023, Abbott launched its innovative heart valve device in India aimed at treating structural heart conditions enhancing patient outcomes. Concurrently, in June 2023, Edwards Lifesciences announced the acquisition of a local competitor, aligning with the growing demand for minimally invasive procedures in the country. Medtronic and Terumo Corporation have also ramped up investments in Research and Development to innovate more effective devices for cardiac care. 

    The Indian government’s push for advanced healthcare technologies, evidenced by initiatives such as the National Health Mission, is propelling growth in this sector. Furthermore, in the last two years, the rising prevalence of cardiovascular diseases has underscored the urgent need for advanced treatment options, fueling market expansion for companies like Stryker and LivaNova. With an increasing focus on cardiovascular health, coupled with the rapid adoption of healthcare technologies in India, the structural heart devices market is positioned for robust growth, benefiting both healthcare providers and patients alike.

    Market Segmentation

    Outlook

    • Replacement Procedures
    • Repair Procedures

    Structural Heart Devices Market Type Outlook

    • Heart Valve Devices
    • Annuloplasty Rings
    • Occluders
    • Delivery Systems

    Structural Heart Devices Market Procedure Outlook

    • Replacement Procedures
    • Repair Procedures

    Structural Heart Devices Market Indication Outlook

    • Valvular Heart Disease
    • Cardiomyopathy

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 35.5(USD Million)
    MARKET SIZE 2024 39.5(USD Million)
    MARKET SIZE 2035 95.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.305% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Cardinal Health, Merit Medical Systems, Terumo Corporation, Edwards Lifesciences, Abbott, Alcon, Stryker, Janssen Pharmaceuticals, Corindus Vascular Robotics, Boston Scientific, LivaNova, AtriCure, Medtronic, Glenveigh Medical, Pleura Technologies
    SEGMENTS COVERED Type, Indication, Procedure
    KEY MARKET OPPORTUNITIES Growing aging population demand, Increasing prevalence of heart diseases, Advancements in minimally invasive procedures, Expanding healthcare infrastructure, Rising awareness and education programs
    KEY MARKET DYNAMICS rising prevalence of heart diseases, increasing aging population, advanced technological innovations, favorable regulatory environment, growing awareness and lifestyle changes
    COUNTRIES COVERED India

    FAQs

    What is the expected market size of the India Structural Heart Devices Market in 2024?

    The India Structural Heart Devices Market is expected to be valued at 39.5 million USD in 2024.

    What will be the market size in 2035?

    By 2035, the market is projected to reach a value of 95.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the market from 2025 to 2035?

    The market is expected to grow at a CAGR of 8.305 percent during the forecast period from 2025 to 2035.

    Which segment is anticipated to be the largest contributor to the market in 2024?

    Heart Valve Devices are projected to be the largest segment in 2024, valued at 15.0 million USD.

    What will be the value of the Annuloplasty Rings segment by 2035?

    The Annuloplasty Rings segment is expected to be valued at 24.0 million USD by 2035.

    Who are the key players in the India Structural Heart Devices Market?

    Major players include Cardinal Health, Edwards Lifesciences, Abbott, and Boston Scientific among others.

    What value is the Occluders segment projected to attain by 2035?

    The Occluders segment is forecasted to reach a value of 19.0 million USD by 2035.

    What are the growth drivers for the India Structural Heart Devices Market?

    Growth is driven by increasing prevalence of heart diseases and advancements in medical technologies.

    What is the expected value of Delivery Systems in 2024?

    The Delivery Systems segment is expected to be valued at 6.5 million USD in 2024.

    How does the current global scenario impact the India Structural Heart Devices Market?

    The market may experience fluctuations due to global supply chain challenges and regulatory changes.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials